Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer

Creative Commons License

Araz M., Soydal Ç., Özkan E., Sen E., Nak D., Kucuk O. N., ...Daha Fazla

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.66, sa.1, ss.61-66, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 66 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.23736/s1824-4785.19.03169-8
  • Dergi Adı: QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.61-66
  • Anahtar Kelimeler: Carcinoma, non-small-cell lung, Positron-emission tomography, Prognosis, EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY, F-18-FDG PET/CT, TUMOR VOLUME, STAGE, SURVIVAL, BURDEN, IMPACT, SUV
  • Ankara Üniversitesi Adresli: Evet

Özet

BACKGROUND: Maximum standardized uptake value (SUVmax) is the primary quantitave parameter given in 18F-FDG PET/CT reports. Calculations derived from three dimensional metabolic volumetric images have been proposed to be more successful than SUVmax alone in prognostification with a lower interobserver variability in many cancers. We aimed to determine the prognostic value of metabolic parameters derived from 18F-FDG PET/CT studies in small cell lung cancer (SCLC) patient population with a long follow-up time.